SMMT

9.9505.87%
MZ

Mahkam Zanganeh

Independent Director

Dr. Mahkam Zanganeh, D.D.S., MBA, also known as Maky, has been a Director of Pulse Biosciences, Inc. since February 09, 2017. Dr. Zanganeh is Founder, President and Chief Executive Officer of Maky Zanganeh and Associates, an executive management and consulting firm founded in 2015. Dr. Zanganeh is Director of Summit Therapeutics Inc since November 23, 2020, serves as its President since July 27, 2022 and Co-Chief Executive Officer since July 27, 2022 and served as its Chief Operating Officer since November 23, 2020 until July 27, 2022 and served as its Non-Executive Director since November 11, 2020 until November 23, 2020. She joined Summit Therapeutics Inc. in November 2020. Dr. Zanganeh served as the Chief Operating Officer of Pharmacyclics LLC (Pharmacyclics Inc.) since August 1, 2012 until September 2015, where she oversaw all clinical, research, commercial and business-related matters. Dr. Zanganeh served as Chief of Staff at Pharmacyclics Inc. from December 2010 to August 1, 2012 and served as its Chief Business Officer from December 2011 to August 1, 2012. She served as Vice President of Business Development at Pharmacyclics Inc. from August 2008 to November 2011. Dr. Zanganeh served as Vice President of Marketing of Pharmacyclics Inc. since August 2008. She was Independent Director of RenovoRx, Inc. since 2018. Dr. Zanganeh played a key role in the multimillion dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc. in 2011. From 1997 to 2008, she held senior positions of increasing responsibility within companies such as Robert Duggan & Associates (a private investment firm) and Computer Motion Inc. From September 2003 to August 2008, she served as Vice President of Business Development at Robert Duggan & Associates. She served as President Director General for the French government initiative biocluster project in France from 2007 to 2008. Prior to joining Duggan & Associates, Dr. Zanganeh served as Worldwide Vice President of Training & Education from 2002 to 2003 and President Director General for Europe, Middle east and Africa at Computer Motion Inc. from 1998 to 2002. Dr. Zanganeh received a DDS degree from Louis Pasteur University in Strasbourg, France and MBA from Schiller International University in France.

Positions